Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality

Overview

About this study

The purpose of this study is to develop a health services registry and repository to prospectively examine patient use of health services and related health outcomes over time among a cohort of adults who have had an order placed for Cologuard.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Resident of the United States.
  • Age 18 years or older.
  • Able to provide informed consent.
  • Able to complete surveys in English or Spanish.
  • Valid order for Cologuard screening.

Exclusion Criteria: 

  • Provisions for inclusion of minorities:
    • Subjects will be included based upon a random selection from among all recipients of a Cologuard test.
    • Minorities will be invited without discrimination by this random process.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Janet Olson, Ph.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available
.
CLS-20467318

Mayo Clinic Footer